This review highlights triazoles' therapeutic potential against prostate cancer, suggesting innovative strategies for treatment.
Prostate cancer continues to pose a significant health challenge, driving the need for innovative therapeutic strategies. Renowned for their varied biological activities, triazoles have shown promise as anticancer agents. The article surveys the most recent advances in the synthesis of triazole derivatives, emphasizing new methodologies and optimization processes. Additionally, it examines the pharmacological effectiveness of triazoles, highlighting their role in targeting and eliminating cancer cells, particularly in prostate cancer, over the last decade. This review also systematically compares the cytotoxic potential of triazole‐based derivatives synthesized over the past decade and highlights their therapeutic relevance against prostate cancer. The compiled findings provide a valuable foundation for selecting promising lead compounds and guiding future in vivo investigations. The review also explores the obstacles and future directions in the development of triazole‐based therapies, aiming to offer a comprehensive understanding of their potential to enhance prostate cancer treatment. By synthesizing current research, this article aims to highlight the promising future of triazoles as a key component in developing more effective and targeted prostate cancer treatments.
No takes yet. Share an insight, caveat, or question.
Bendi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: